New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
09:14 EDTELY, UAL, DD, MSFT, SYNA, ABBV, DECK, QLIK, UPS, AMZN, RMD, MKTO, YHOO, CECO, ZNGA, ESRX, HWAYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Zynga (ZNGA), up 12%... Amazon (AMZN), up 7%... Microsoft (MSFT), up 6%... UPS (UPS), up 2%... Deckers Outdoor (DECK), up 14%... Callaway Golf (ELY), up 10%... Marketo (MKTO), up 9%... AbbVie (ABBV), up 2%. ALSO HIGHER: DuPont (DD), up 1.5% after announcing a plan to spin-off its Performance Chemicals segment... Career Education (CECO), up 52% after announcing a deal to sell its European properties for $305M. DOWN AFTER EARNINGS: Qlik Technologies (QLIK), down 19%... Healthways (HWAY), down 25%... ResMed (RMD), down 8%... Synaptics (SYNA), down 5.6%... Express Scripts (ESRX), down 3%. ALSO LOWER: Yahoo (YHOO), down 2% after South China Morning Post said Alibaba, in which Yahoo has a large stake, has postponed the listing its shares.
News For AMZN;MSFT;ZNGA;UPS;DD;CECO;QLIK;UAL;YHOO;DECK;ELY;MKTO;ABBV;HWAY;RMD;SYNA;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
December 4, 2014
16:27 EDTMSFTOn The Fly: Closing Wrap
Subscribe for More Information
16:21 EDTSYNASynaptics announces retirement of CFO Kathleen Bayless
Subscribe for More Information
16:20 EDTSYNASynaptics raises Q2 revenue view to $440M-$460M from $415M-$450M
Subscribe for More Information
16:00 EDTAMZNOptions Update; December 4, 2014
Subscribe for More Information
12:34 EDTMSFTMicrosoft advances after analyst hikes target on upbeat earnings forecast
Subscribe for More Information
12:22 EDTMSFTOn The Fly: Midday Wrap
Stocks on Wall Street began the session slightly lower despite relatively in-line jobless claims data, as European markets moved down following a rate decision and accompanying commentary from ECB President Mario Draghi. Adding to the modest pressure seen in morning trading may be the fact that oil prices continue to move lower. ECONOMIC EVENTS: In the U.S., initial jobless claims fell 17K to 297K in the week ended November 29, which was nearly in-line with the expectation for 295K first-time claims. Challenger reported announced layoffs fell 15.2K in November to 35.9K. In Europe, the European Central Bank kept its key rates unchanged, as expected. ECB President Mario Draghi said in his accompanying press conference that the latest euro area macroeconomic projections indicate lower inflation, accompanied by weaker real GDP growth and subdued monetary dynamics. Additionally, he stated that early next year the Governing Council will reassess the monetary stimulus achieved, the expansion of the balance sheet and the outlook for price developments. "Should it become necessary to further address risks of too prolonged a period of low inflation, the Governing Council remains unanimous in its commitment to using additional unconventional instruments within its mandate. This would imply altering early next year the size, pace and composition of our measures," Draghi said. COMPANY NEWS: Shares of Barnes and Noble (BKS) slid about 10% after the company reported lower than expected second quarter earnings and said it continues to expect both Retail comparable bookstore sales and Retail Core comparable bookstore sales to decline in the low-single digits this fiscal year. Additionally, Barnes & Noble and Microsoft (MSFT) agreed to terminate their commercial agreement and B&N agreed to acquire Microsoft's entire preferred interest in NOOK Media in exchange for $62.4M cash and 2.74M shares of its stock. MAJOR MOVERS: Among the notable gainers was Hawaiian Electric (HE), which jumped 16% after its board approved a plan to spin off ASB Hawaii, the parent company for American Savings Bank, and establish it as an independent publicly traded company and NextEra Energy (NEE) agreed to acquire the company, excluding the banking subsidiary. Array BioPharma (ARRY) rose 15% after announcing it has reached a definitive agreement with Novartis (NVS) to regain full worldwide rights to binimetinib, a MEK inhibitor in three Phase 3 trials, which Piper Jaffray called a "big win" for the company. Among the noteworthy losers was UTi Worldwide (UTIW), which fell 11.5% after confirming that exploratory conversations have taken place with DSV, but adding those discussions never progressed beyond a preliminary stage and that no talks are currently taking place. Also lower were shares of Express (EXPR), which declined over 9% after the apparel retailer reported lower than expected Q3 revenue and gave EPS guidance that fell short of estimates. INDEXES: Near midday, the Dow was down 53.56, or 0.3%, to 17,859.06, the Nasdaq was down 2.80, or 0.06%, to 4,771.67, and the S&P 500 was down 5.49, or 0.26%, to 2,068.84.
10:18 EDTUALAirline stocks lifted following JPMorgan valuation call
Subscribe for More Information
10:08 EDTMSFTBarnes & Noble says Pearson continues to have 5% interest in Nook Media LLC
Subscribe for More Information
09:37 EDTAMZNActive equity options trading
Active equity options trading according to Track Data: AAPL ALTR P BIDU AMZN TSLA X NFLX TWTR WMT
09:01 EDTAMZNAmazon launches Amazon Elements everyday essentials product line
Subscribe for More Information
09:01 EDTABBVVA negotiated $594 per dose price for Gilead HCV treatment
A Veterans Health Administration official told a Senate committee yesterday that Veterans' Affairs has "moved rapidly to deploy new, more effective, less toxic HCV treatments and has been able to negotiate significant discounts for these newer therapies." The agency negotiated a price of $594 per dose for Gilead's (GILD) Hepatitis C virus drug Sofosbuvir, below the commercial price of $1,000 per dose, VHA Chief Consultant for Pharmacy Benefits Management Michael Valentino told the Senate's Committee on Veterans' Affairs. The agency also received a $413 per dose price for Johnson & Johnson's (JNJ) Simeprevir, below the commerical price of $790. The VA has approximately 174,000 veterans in care with HCV, making it the largest single HCV provider in the U.S., Valentino pointed out. He added, "Like the rest of the country, VA has treated only a portion of Veterans for HCV because treatment and cures have been difficult to achieve due to low efficacy and high toxicity of standard drug therapies." Reference Link
08:46 EDTMSFTBarnes & Noble to pay $62.4M, 2.74M shares for Microsoft Nook stake
08:45 EDTAMZNAmazon.com, ChannelAdvisor should be bought, says Pacific Crest
Subscribe for More Information
08:45 EDTABBVAbbVie price target raised to $80 from $72 at Jefferies
Jefferies raised its price target for AbbVie shares to $80 while calling the company one of its top five global pharma picks for 2015. The firm's top U.S. pick is Pfizer (PFE) and its top Europe pick is Novartis (NVS). Bayer (BAYRY) and AstraZeneca (AZN) round out the top five. Jefferies thinks AbbVie's "strong momentum" will continue into the first half of 2015 and keeps a Buy rating on the name.
08:44 EDTMSFTBarnes & Noble to acquire preferred interest in NOOK Media from Microsoft
Barnes & Noble (BKS) filed a Form 8-K with the SEC stating that Barnes & Noble and Microsoft (MSFT) have agreed to terminate their commercial agreement including any associated obligations for international content acquisition and sale. Such termination will allow the company to continue its rationalization of the NOOK Digital business and enhances Barnes & Noble’s operational and strategic flexibility. The termination also relieves Microsoft of any obligation to continue to fund support and other payments set forth in the commercial agreement between the partners. Additionally, the company stated that it had entered into an agreement with Microsoft to acquire its entire preferred interest in NOOK Media, LLC. As a result of today’s announcement, Barnes & Noble expects that the completion of the potential separation of the company's businesses could occur by the end of August 2015, although there can be no assurances regarding the timing of such potential separation or that such separation will be completed.
07:53 EDTUPSUPS management to meet with UBS
Meeting to be held in Sydney, Australia on December 4 hosted by UBS.
07:51 EDTDECKDeckers Outdoor shares going to $130, says Jefferies
Jefferies predicts shares of Deckers Outdoor are going to $130 after hosting investor meetings with management. The firm says management was "very upbeat" regarding the start of the holiday season. Jefferies thinks next year's UGG offerings will continue to drive positive momentum in 2015. It reiterates a Buy rating on Deckers with a $130 price target. Shares of the UGG maker rose 68c yesterday to $96.54.
07:26 EDTUALJPMorgan says Airlines more attractive today than two months ago
Subscribe for More Information
07:25 EDTMSFTMicrosoft price target raised to $56 from $50 at Nomura
Nomura raised Microsoft's price target to $56 to reflect the new Board's potential return of cash to shareholders. The analyst believes the Board is looking at several scenarios that include a leveraged recapitalization to buy back half its stock over a multi-year period, to a more likely, 5%-10% repurchase of shares. The firm rates shares a Buy.
06:02 EDTAMZNStocks with implied volatility movement; BAC AMZN
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use